• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

因 COVID-19 入院患者临床恶化的危险因素:一项病例对照研究。

Risk factors for clinical deterioration in patients admitted for COVID-19: A case-control study.

机构信息

Servicio de Respiratorio, Hospital Galdakao-Usansolo, Galdakao, Bizkaia, Spain.

Unidad de Investigación Hospital Galdakao-Usansolo, Galdakao, Bizkaia, Spain.

出版信息

Rev Clin Esp (Barc). 2022 Jan;222(1):22-30. doi: 10.1016/j.rceng.2021.04.009. Epub 2021 Sep 9.

DOI:10.1016/j.rceng.2021.04.009
PMID:34556435
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8426292/
Abstract

INTRODUCTION

There is controversy regarding the best predictors of clinical deterioration in COVID-19.

OBJECTIVE

This work aims to identify predictors of risk factors for deterioration in patients hospitalized due to COVID-19.

METHODS DESIGN

Nested case-control study within a cohort.

SETTING

13 acute care centers of the Osakidetza-Basque Health Service.

PARTICIPANTS

patients hospitalized for COVID-19 with clinical deterioration-defined as onset of severe ARDS, ICU admission, or death-were considered cases. Two controls were matched to each case based on age. Sociodemographic data; comorbidities; baseline treatment; symptoms; date of onset; previous consultations; and clinical, analytical, and radiological variables were collected. An explanatory model of clinical deterioration was created by means of conditional logistic regression.

RESULTS

A total of 99 cases and 198 controls were included. According to the logistic regression analysis, the independent variables associated with clinical deterioration were: emergency department O saturation ≤90% (OR 16.6; 95%CI 4-68), pathological chest X-ray (OR 5.6; 95%CI 1.7-18.4), CRP > 100 mg/dL (OR 3.62; 95%CI 1.62-8), thrombocytopenia with <150,000 platelets (OR 4; 95%CI 1.84-8.6); and a medical history of acute myocardial infarction (OR 15.7; 95%CI, 3.29-75.09), COPD (OR 3.05; 95%CI 1.43-6.5), or HT (OR 2.21; 95%CI 1.11-4.4). The model's AUC was 0.86. On the univariate analysis, female sex and presence of dry cough and sore throat were associated with better clinical progress, but were not found to be significant on the multivariate analysis.

CONCLUSION

The variables identified could be useful in clinical practice for the detection of patients at high risk of poor outcomes.

摘要

简介

关于 COVID-19 临床恶化的最佳预测因素存在争议。

目的

本研究旨在确定因 COVID-19 住院的患者恶化风险因素的预测因子。

方法设计

队列内嵌套病例对照研究。

设置

奥萨基塔萨巴斯克卫生服务的 13 个急性护理中心。

参与者

临床恶化的 COVID-19 住院患者(定义为严重 ARDS 发作、入住 ICU 或死亡)被视为病例。根据年龄,每个病例匹配了 2 个对照。收集了人口统计学数据;合并症;基线治疗;症状;发病日期;先前就诊;以及临床、分析和影像学变量。通过条件逻辑回归创建临床恶化的解释模型。

结果

共纳入 99 例病例和 198 例对照。根据逻辑回归分析,与临床恶化相关的独立变量包括:急诊科 O 饱和度≤90%(OR 16.6;95%CI 4-68)、病理性胸部 X 线(OR 5.6;95%CI 1.7-18.4)、CRP>100mg/dL(OR 3.62;95%CI 1.62-8)、血小板计数<150,000/μL(OR 4;95%CI 1.84-8.6);以及急性心肌梗死(OR 15.7;95%CI,3.29-75.09)、COPD(OR 3.05;95%CI 1.43-6.5)或 HT(OR 2.21;95%CI 1.11-4.4)的病史。该模型的 AUC 为 0.86。在单变量分析中,女性和干咳和喉咙痛的存在与更好的临床进展相关,但在多变量分析中未发现有统计学意义。

结论

确定的变量在临床实践中可能有助于检测预后不良风险较高的患者。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1dd4/8426292/6e8e0ab82d08/gr2_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1dd4/8426292/0f3a0c36a2c8/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1dd4/8426292/6e8e0ab82d08/gr2_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1dd4/8426292/0f3a0c36a2c8/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1dd4/8426292/6e8e0ab82d08/gr2_lrg.jpg

相似文献

1
Risk factors for clinical deterioration in patients admitted for COVID-19: A case-control study.因 COVID-19 入院患者临床恶化的危险因素:一项病例对照研究。
Rev Clin Esp (Barc). 2022 Jan;222(1):22-30. doi: 10.1016/j.rceng.2021.04.009. Epub 2021 Sep 9.
2
[Risk factors for clinical deterioration in patients admitted for COVID-19: A case-control study].[新型冠状病毒肺炎住院患者临床病情恶化的危险因素:一项病例对照研究]
Rev Clin Esp. 2022 Jan;222(1):22-30. doi: 10.1016/j.rce.2021.04.007. Epub 2021 May 24.
3
Predictors of clinical deterioration in non-severe patients with COVID-19: a retrospective cohort study.新型冠状病毒肺炎非重症患者临床恶化的预测因素:一项回顾性队列研究。
Curr Med Res Opin. 2021 Mar;37(3):385-391. doi: 10.1080/03007995.2021.1876005. Epub 2021 Feb 4.
4
Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.COVID-19 住院成人患者使用伊马替尼的安全性和疗效:一项随机对照试验研究方案的结构化总结。
Trials. 2020 Oct 28;21(1):897. doi: 10.1186/s13063-020-04819-9.
5
Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial.评估 BIO101 预防 COVID-19 肺炎患者呼吸恶化的疗效和安全性(COVA 研究):一项随机对照试验研究方案的结构化总结。
Trials. 2021 Jan 11;22(1):42. doi: 10.1186/s13063-020-04998-5.
6
Multiparametric correlation of laboratory biomarkers to multiorgan failure outcome in hospitalized COVID-19 patients: a retrospective observational study.多参数关联实验室生物标志物与住院 COVID-19 患者多器官衰竭结局:一项回顾性观察研究。
Eur Rev Med Pharmacol Sci. 2023 Sep;27(18):8962-8974. doi: 10.26355/eurrev_202309_33817.
7
Risk factors and early prediction of clinical deterioration and mortality in adult COVID-19 inpatients: an Australian tertiary hospital experience.成人 COVID-19 住院患者临床恶化和死亡的危险因素及早期预测:澳大利亚一家三级医院的经验。
Intern Med J. 2022 Apr;52(4):550-558. doi: 10.1111/imj.15631.
8
Predictors of clinical deterioration in patients with suspected COVID-19 managed in a 'virtual hospital' setting: a cohort study.疑似 COVID-19 患者在“虚拟医院”环境中管理的临床恶化预测因素:一项队列研究。
BMJ Open. 2021 Mar 23;11(3):e045356. doi: 10.1136/bmjopen-2020-045356.
9
Clinical characteristics and outcome of Covid-19 illness and predictors of in-hospital mortality in Saudi Arabia.沙特阿拉伯的新冠病毒疾病的临床特征和转归以及住院死亡率的预测因素。
BMC Infect Dis. 2022 Dec 17;22(1):950. doi: 10.1186/s12879-022-07945-8.
10
Clinical and Epidemiological Features of SARS-CoV-2 Patients in SARI Ward of a Tertiary Care Centre in New Delhi.新德里一家三级医疗中心SARI病房中新冠病毒患者的临床和流行病学特征
J Assoc Physicians India. 2020 Jul;68(7):19-26.

引用本文的文献

1
Predictors to Intensive Care Unit admission among patient with coronavirus disease in Sukraraj Tropical and Infectious Disease Hospital, Nepal: A case-control study.尼泊尔苏克拉拉杰热带病与传染病医院新冠肺炎患者入住重症监护病房的预测因素:一项病例对照研究
PLOS Glob Public Health. 2024 Mar 21;4(3):e0002516. doi: 10.1371/journal.pgph.0002516. eCollection 2024.
2
Interleukin-28 as a Promising Marker for Predicting Invasive Mechanical Ventilation Requirement and Mortality in COVID-19 Patients.白细胞介素-28作为预测COVID-19患者有创机械通气需求和死亡率的有前景标志物
Thorac Res Pract. 2023 Mar;24(2):61-65. doi: 10.5152/ThoracResPract.2023.22146.

本文引用的文献

1
[Clinical characteristics of patients hospitalized with COVID-19 in Spain: Results from the SEMI-COVID-19 Registry].[西班牙新冠肺炎住院患者的临床特征:SEMI-COVID-19登记研究结果]
Rev Clin Esp. 2020 Nov;220(8):480-494. doi: 10.1016/j.rce.2020.07.003. Epub 2020 Jul 19.
2
Clinical Characteristics and Prognosis of COPD Patients Hospitalized with SARS-CoV-2.感染新型冠状病毒肺炎住院的慢性阻塞性肺疾病患者的临床特征及预后
Int J Chron Obstruct Pulmon Dis. 2021 Jan 5;15:3433-3445. doi: 10.2147/COPD.S276692. eCollection 2020.
3
Development and validation of the ISARIC 4C Deterioration model for adults hospitalised with COVID-19: a prospective cohort study.
ISARIC 4C 成人 COVID-19 恶化模型的开发和验证:一项前瞻性队列研究。
Lancet Respir Med. 2021 Apr;9(4):349-359. doi: 10.1016/S2213-2600(20)30559-2. Epub 2021 Jan 11.
4
Admission hyperglycaemia as a predictor of mortality in patients hospitalized with COVID-19 regardless of diabetes status: data from the Spanish SEMI-COVID-19 Registry.无论患者是否患有糖尿病,住院 COVID-19 患者的入院高血糖症可预测其死亡率:来自西班牙 SEMI-COVID-19 登记处的数据。
Ann Med. 2021 Dec;53(1):103-116. doi: 10.1080/07853890.2020.1836566.
5
Association of Hypertension with All-Cause Mortality among Hospitalized Patients with COVID-19.新冠肺炎住院患者中高血压与全因死亡率的关联
J Clin Med. 2020 Sep 28;9(10):3136. doi: 10.3390/jcm9103136.
6
The need for an independent evaluation of the COVID-19 response in Spain.对西班牙应对新冠疫情情况进行独立评估的必要性。
Lancet. 2020 Aug 22;396(10250):529-530. doi: 10.1016/S0140-6736(20)31713-X. Epub 2020 Aug 6.
7
Does poor glucose control increase the severity and mortality in patients with diabetes and COVID-19?血糖控制不佳会增加糖尿病合并新冠病毒肺炎患者的病情严重程度及死亡率吗?
Diabetes Metab Syndr. 2020 Sep-Oct;14(5):725-727. doi: 10.1016/j.dsx.2020.05.037. Epub 2020 May 27.
8
Predictive symptoms and comorbidities for severe COVID-19 and intensive care unit admission: a systematic review and meta-analysis.预测严重 COVID-19 和入住重症监护病房的症状和合并症:系统评价和荟萃分析。
Int J Public Health. 2020 Jun;65(5):533-546. doi: 10.1007/s00038-020-01390-7. Epub 2020 May 25.
9
Prognostic factors in patients with diabetes hospitalized for COVID-19: Findings from the CORONADO study and other recent reports.COVID-19 住院糖尿病患者的预后因素:CORONADO 研究及其他近期报告的结果。
Diabetes Metab. 2020 Sep;46(4):265-271. doi: 10.1016/j.diabet.2020.05.008. Epub 2020 May 21.
10
Advances in the relationship between coronavirus infection and cardiovascular diseases.冠状病毒感染与心血管疾病关系的研究进展。
Biomed Pharmacother. 2020 Jul;127:110230. doi: 10.1016/j.biopha.2020.110230. Epub 2020 May 13.